BPC157, a synthetic peptide known for its regenerative properties, is gaining attention in Australia and globally for its potential healing effects. Despite strong preclinical studies, human clinical data remains limited and low-quality. Ongoing trials could pave the way for future research, emphasizing the need for rigorous studies on its efficacy and safety.